BRAF and neoplasm: A recent study showed a sustained proliferative phenotype of SOX2+ cells in human PCP (known to predominantly harbor BRAF mutations), and advanced the hypothesis that these cells may be driving the growth of the tumor because they represent the major proliferative cell population within the tumor (34).